Drugs / NOX-100
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT01672008 | Aug 2012 → Jul 2015 | hypotensive disorder | Medinox, Inc. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | NOX-100 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01672008 ↗ |
| Modality | Small molecule | — CHEMBL4301787 ↗ |